IP Library Granted Patent US 9,242,857
Granted Patent B2
US 9,242,857 · App. 13/210,047 · Granted Jan 26, 2016

Yeast cell wall particles for receptor-targeted nanoparticle delivery

Inventors: Gary R. Ostroff (Worcester, MA); Ernesto Soto (Worcester, MA)
Assignee: University of Massachusetts
B82Y5/00A61K9/5068A61K9/5115A61K47/489A61K47/4893A61K47/48853A61K35/66
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,242,857
App. No.
13/210,047
Granted
Jan 26, 2016
Kind
B2
Abstract

The present invention generally relates to yeast cell wall microparticles loaded with nanoparticles for receptor-targeted nanoparticle delivery. In particular, the present invention relates to trapping nanoparticles either on the surface or inside a yeast glucan particles, for example, yeast glucal particles. The present invention further relates to methods of making the yeast cell wall particles loaded with nanoparticles. The present invention also relates to methods of using the yeast cell wall particles loaded with nanoparticles for receptor-targeted delivery of the nanoparticles, e.g., drug containing nanoparticles.

Claims (22)

1. A method for making a YCWP-NP delivery system, comprising yeast cell wall particles (YCWPs) comprising nanoparticles (NPs) having at least one dimension of about 1-40 nm contained within the interior of the YCWPs, the method comprising the steps of:

(a) loading the NPs into the YCWPs, wherein the loading comprises incubating a suspension comprising YCWPs and NPs for a time sufficient for the NPs to enter into the YCWPs,

(b) drying the material resulting from (a),

(c) optionally repeating steps (a)-(b) at least once,

(d) resuspending the YCWPs and nanoparticles in a solvent for a time sufficient for additional NPs to enter into the YCWPs,

(e) optionally drying the material resulting from (d), and

(f) optionally trapping the NPs in the YCWPs using an appropriate trapping means, such that the YCWP-NP delivery system is made;

wherein the NPs are insoluble in water.

2. The method of claim 1 , wherein the NPs have at least one dimension of about 2-40 nm.

3. The method of claim 1 , wherein the NPs have at least one dimension of about 5-30 nm.

4. The method of claim 1 , wherein the NPs have at least one dimension of about 10-30 nm.

5. The method of claim 1 , wherein the YCWPs are selected from the group consisting of YGPs, YGMPs, YCPs and YGCPs.

6. The method of claim 5 , wherein the YCWPs are YGPs.

7. The method of claim 1 , wherein the loading comprises incubating the suspension for about 1-2 hours.

8. The method of claim 1 , wherein the solvent is saline or water.

9. The method of claim 1 , wherein the nanoparticles are selected from the group consisting of quantum dots, gold particles and magnetic particles.

10. The method of claim 1 , wherein the trapping means is selected from the group consisting of a physical trapping means, an electrostatic trapping means, an affinity trapping means, and a hydrophobic trapping means.

11. The method of claim 1 , wherein the trapping means is an electrostatic trapping means.

12. The method of claim 11 , wherein the electrostatic trapping results from interaction of an anionic nanoparticle with a cationic polymeric trapping molecule or of a cationic nanoparticle with an anionic polymeric trapping molecule.

13. The method of claim 1 , wherein the trapping means is physical trapping.

14. The method of claim 13 , wherein the physical trapping results from interaction of the nanoparticle with a trapping molecule selected from the group consisting of alginate and chitosan.

15. The method of claim 12 , wherein the interaction is of the anionic nanoparticle with the cationic polymeric trapping molecule and wherein the cationic polymeric trapping molecule comprises polyethyleneimine, polylysine, chitosan, or protamine.

Assignments (3)
CONFIRMATORY LICENSE Recorded Apr 12, 2017
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042232/0031 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2016
From: OSTROFF, GARY R.; SOTO, ERNESTO
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 037573/0458 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2011
From: OSTROFF, GARY R.; SOTO, ERNESTO
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 026823/0900 →
Continuity (2)
Provisional Application 61373828 · Aug 14, 2010
Related Publication 20120070376A1 · Mar 22, 2012